|
|
Blood, 1 April 2008, Vol. 111, No. 7, pp. 3838-3848.
Prepublished online as a Blood First Edition Paper on January 25, 2008; DOI 10.1182/blood-2007-11-125450.
 Previous Article | Next Article 
Submitted November 27, 2007
Accepted January 19, 2008
A new perspective: molecular motifs on oxidized-LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies
Anna Lanemo Myhrinder, Eva Hellqvist, Ekaterina Sidorova, Anita Soderberg, Helen Baxendale, Charlotte Dahle, Kerstin Willander, Gerard Tobin, Eva Backman, Ola Soderberg, Richard Rosenquist, Sohvi Horkko, and Anders Rosen*
Department of Clinical and Experimental Medicine, Linkoping University, Linkoping, Sweden
Infectious Disease & Microbiology Unit, Institute of Child Health, University of London Medical School, London, United Kingdom
Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden
Department of Pharmacology and Toxicology and Biocenter Oulu, University of Oulu, and Clinical Research Center, Oulu University Hospital, Oulu, Finland
* Corresponding author; email: anders.rosen{at}ibk.liu.se.
The restricted immunoglobulin (Ig) repertoire found in B-cell chronic lymphocytic leukemia (CLL) implies a role for antigen(s) in the leukemogenesis. The nature of the antigens have, however, not been characterized, although examples of autoantigens have been demonstrated. We have analyzed a panel of twenty-eight CLL cell lines and primary cultures, producing monoclonal Ig with different Ig heavy-chain variable region gene usage and mutational status, including several complementarity determining region 3 homology subset members. Using mass-spectrometry, immunoassays, or protein-macroarrays, we have discovered novel antigens binding to CLL Igs. These antigens included cytoskeletal proteins vimentin, filamin B, and cofilin-1, but also phosphorylcholine-containing antigens e.g. Streptococcus pneumoniae polysaccharides and oxidized-LDL. Additional new antigens identified were cardiolipin and proline-rich acidic protein-1. Remarkably, these antigens represent molecular motifs exposed on apoptotic cells/blebs and bacteria; and several CLL Igs bound to apoptotic Jurkat cells. In conclusion, these intriguing data, showing a limited target structure recognition, indicate that CD5+ CLL B-cells are derived from a cell-compartment that produces 'natural antibodies', which may be instrumental in elimination and scavenging of apoptotic cells and pathogenic bacteria.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
L.-A. Sutton, E. Kostareli, A. Hadzidimitriou, N. Darzentas, A. Tsaftaris, A. Anagnostopoulos, R. Rosenquist, and K. Stamatopoulos
Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen
Blood,
November 12, 2009;
114(20):
4460 - 4468.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. McElligott, E. N. Maginn, L. M. Greene, S. McGuckin, A. Hayat, P. V. Browne, S. Butini, G. Campiani, M. A. Catherwood, E. Vandenberghe, et al.
The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia
Cancer Res.,
November 1, 2009;
69(21):
8366 - 8375.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Stamatopoulos
CLL: promiscuity leads to risks
Blood,
October 22, 2009;
114(17):
3508 - 3509.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Seiler, M. Woelfle, S. Yancopoulos, R. Catera, W. Li, K. Hatzi, C. Moreno, M. Torres, S. Paul, H. Dohner, et al.
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells
Blood,
October 22, 2009;
114(17):
3615 - 3624.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Burger, P. Ghia, A. Rosenwald, and F. Caligaris-Cappio
The microenvironment in mature B-cell malignancies: a target for new treatment strategies
Blood,
October 15, 2009;
114(16):
3367 - 3375.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Rossi, V. Spina, M. Cerri, S. Rasi, C. Deambrogi, L. De Paoli, L. Laurenti, R. Maffei, F. Forconi, F. Bertoni, et al.
Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
Clin. Cancer Res.,
July 1, 2009;
15(13):
4415 - 4422.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S MacCallum, M Groves, D Brass, J Cunningham, M Sales, K Gelly, and S Tauro
Autoimmune pancytopenia following combination chemotherapy for chronic lymphocytic leukaemia
J. Clin. Pathol.,
May 1, 2009;
62(5):
468 - 470.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Hadzidimitriou, N. Darzentas, F. Murray, T. Smilevska, E. Arvaniti, C. Tresoldi, A. Tsaftaris, N. Laoutaris, A. Anagnostopoulos, F. Davi, et al.
Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia
Blood,
January 8, 2009;
113(2):
403 - 411.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. C. Chu, R. Catera, K. Hatzi, X.-J. Yan, L. Zhang, X. B. Wang, H. M. Fales, S. L. Allen, J. E. Kolitz, K. R. Rai, et al.
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA
Blood,
December 15, 2008;
112(13):
5122 - 5129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. Chang, H. Deng, P. Matthews, J. Krasovsky, G. Ragupathi, R. Spisek, A. Mazumder, D. H. Vesole, S. Jagannath, and M. V. Dhodapkar
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer
Blood,
August 15, 2008;
112(4):
1308 - 1316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Plate
Signals that maintain leukemic cell viability
Blood,
July 1, 2008;
112(1):
1 - 2.
[Full Text]
[PDF]
|
|
|
|
|
